Although all European countries have vaccination policies for children, there are no comprehensive studies of pediatric vaccination programs in Europe. We studied vaccination programs for children in Europe. Vaccinations against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b, hepatitis B, measles, mumps, rubella, and influenza existed in 42 countries, against human papilloma virus in 41 countries, and against pneumococcus in 40 countries. In addition, the following vaccinations existed: against tuberculosis (35 countries), hepatitis A (33), meningococcus A, C, W, Y (30), rotavirus and varicella (28 countries each), meningococcus B (24), tick-born encephalitis (22), and meningococcus C (16). Mandatory vaccinations are implemented in 21 countries, mainly against diphtheria, tetanus, pertussis, poliomyelitis, H. influenzae type b, hepatitis B, measles, mumps, rubella, tuberculosis, and pneumococcus. There are significant differences among pediatric vaccination programs in Europe regarding number, schedules, indications, and regulatory frame (recommended or mandatory vaccinations). A consensus-based vaccination program for all children is needed.
AllerbergerF (2017) Eliminating measles and rubella in Europe. Clinical Microbiology and Infection23: 502–503. DOI: 10.1016/j.cmi.2017.04.008.
2.
Ardura-GarciaCKreisCRakicM, et al. (2021) Rotavirus disease and health care utilisation among children under 5 years of age in highly developed countries: a systematic review and meta-analysis. Vaccine39: 2917–2928. DOI: 10.1016/j.vaccine.2021.04.039.
3.
BitzegeioJBukowskiBHausnerM, et al. (2020) Two measles clusters in connection with short inner-European air travels indicating impediments to effective measles control: a cluster analysis. Travel Medicine and Infectious Disease33: 101542. DOI: 10.1016/j.tmaid.2019.101542.
4.
CassimosDCEffraimidouEMedicS, et al. (2020) Vaccination programs for adults in Europe, 2019. Vaccines8: 34. DOI: 10.3390/vaccines8010034.
DohertyMBuchyPStandaertB, et al. (2016) Vaccine impact: benefits for human health. Vaccine34: 6707–6714. DOI: 10.1016/j.vaccine.2016.10.025.
9.
DretlerAWRouphaelNGStephensDS (2018) Progress toward the global control of neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development. Human Vaccines & Immunotherapeutics14: 1146–1160. DOI: 10.1080/21645515.2018.1451810.
European Centre for Disease Prevention and Control (2020b) Vaccine scheduler. Available fromhttps://vaccine-schedule.ecdc.europa.eu/ (accessed 18 December 2020).
13.
European Commission (2018) Press release: vaccination: commission calls for stronger EU cooperation against preventable diseases. Available from: http://europa.eu/rapid/press-release_IP-18-3457_en.htm (accessed 18 December 2020).
EythorssonEÁsgeirsdóttirTLErlendsdóttirH, et al. (2021) The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland-A population-based time series analysis. PloS One16: e0249497. DOI: 10.1371/journal.pone.0249497.
16.
GossnerCMSeveriEDanielssonN, et al. (2015) Changing hepatitis A epidemiology in the European union: new challenges and opportunities. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin20(16). pii=21101, Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=21101
17.
GualanoMOliveroEVoglinoG, et al. (2019) Knowledge, attitudes and beliefs towards compulsory vaccination: a systematic review. Human Vaccines & Immunotherapeutics15(4): 918–931. DOI: 10.1080/21645515.2018.1564437.
18.
HoltE (2018) 41 000 measles cases in Europe since the beginning of 2018. Lancet392: 724. DOI: 10.1016/S0140-6736(18)32031-2.
19.
HotezPJNuzhathTColwellB (2020) Combating vaccine hesitancy and other 21st century social determinants in the global fight against measles. Current Opinion in Virology41: 1–7. Available from: https://pubmed.ncbi.nlm.nih.gov/32113136/
20.
KirolosAWaughCTempletonK, et al. (2018) Imported case of measles in a university setting leading to an outbreak of measles in Edinburgh, Scotland from September to December 2016. Epidemiology and Infection146: 741–746. DOI: 10.1017/S0950268818000602. Epub 2018 Mar 22.
21.
LangSLovingSMcCarthyND, et al. (2020) Two centuries of immunisation in the UK (part II). Archives of Disease in Childhood105: 216–222. Available from: https://pubmed.ncbi.nlm.nih.gov/31302603/
22.
LopalcoPLde CarvalhoHGKreidlP, et al. (2009) Childhood vaccination schedules in Europe vary widely. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz52: 1095–1098. DOI: 10.1007/s00103-009-0960-z.
23.
MaltezouHCBotelho-NeversEBrantsæterAB, et al. (2019a) Vaccination of healthcare personnel in Europe: update to current policies. Vaccine37: 7576–7584. DOI: 10.1016/j.vaccine.2019.09.061.
24.
MaltezouHCLeddaCRapisardaV (2019b) Mandatory vaccinations for children in Italy: the need for a stable frame. Vaccine37: 4419–4420. https://pubmed.ncbi.nlm.nih.gov/31280946/
Nguyen-HuuN-HThillyNDerroughT, et al. (2020) Human papillomavirus vaccination coverage, policies, and practical implementation across Europe. Vaccine38: 1315–1331. DOI: 10.1016/j.vaccine.2019.11.081.
27.
NicholKL (2011) Cost-effectiveness and socio-economic aspects of childhood influenza vaccination. Vaccine29: 7554–7558. Available from: https://pubmed.ncbi.nlm.nih.gov/21820477/
28.
PatelCBrothertonJMPillsburyA, et al. (2018) The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?Eurosurveillance23: 41. DOI: 10.2807/1560-7917.ES.2018.23.41.1700737.
29.
PavliAMaltezouH (2017) Health problems of newly arrived migrants and refugees in Europe. Journal of Travel Medicine24: 4. DOI: 10.1093/jtm/tax016.
30.
SheikhSBiundoECourcierS, et al. (2018) A report on the status of vaccination in Europe. Vaccine36: 4979–4992. DOI: 10.1016/j.vaccine.2018.06.044.
31.
SiraJBrownMAmbegaokarS, et al. (2019) The necessity of education and hepatitis B vaccination for young people: a study of high risk behaviour for blood borne viruses in the United Kingdom. Journal of Child Health Care23: 437–445. Available from: https://journals.sagepub.com/doi/10.1177/1367493519831499
32.
SmithLEAmlôtRWeinmanJ, et al. (2017) A systematic review of factors affecting vaccine uptake in young children. Vaccine35: 6059–6069. DOI: 10.1016/j.vaccine.2017.09.046.
33.
StaehelinCChernetASydowV, et al. (2019) Seroprotection rates of vaccine-preventable diseases among newly arrived eritrean asylum seekers in Switzerland: a cross-sectional study. Journal of Travel Medicine26. taz035. DOI: 10.1093/jtm/taz035.
34.
TaylorKNguyenAStéphenneJ (2009) The need for new vaccines. Vaccine27(suppl. 6): G3–G8. DOI: 10.1016/j.vaccine.2009.10.014.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
